Fraud & Compliance Risk Review.

Aegis gives investors a defensible view of revenue quality, contract strength, and regulatory risk—before capital moves. We validate what’s in the deck, quantify what isn’t, and map the truth behind the revenue so you buy with confidence (or walk away fast).

Before you buy the business, know if you’re inheriting FWA exposure or compliance liabilities that follow you post-close. We surface coordinated patterns, documentation gaps, and regulatory risks that won’t survive scrutiny—then quantify potential impact so you can price it, paper it, or walk away. Findings are evidence-first and built to stand up in diligence rooms and litigation.

What To Expect:

  • Pattern Analytics: upcoding/unbundling, time/volume anomalies, duplicate/ghost billing, referral/ownership loops.
  • Provider & Network Integrity: licensing, credentialing, exclusions/sanctions, supervision/scope-of-practice compliance.
  • Documentation & Medical Necessity: sample reviews mapped to LCD/NCD and plan policies; sufficiency and consistency checks.
  • Prior Audits & Repayments: open/historic investigations, corrective action plans, record-retention risk.
  • Financial Exposure Sizing: overpayment estimates, reversal risk, and reserve guidance.

What To Expect From Us:

  • Risk Register (red/yellow/green) with quantified exposure and likelihood.
  • Evidence Packs: exemplars, citations, timelines, and methodology.
  • Exposure Model: range of potential repayments, offsets, and sensitivity to audit posture.
  • Remediation Roadmap: pre- and post-close actions; provider education and network hygiene.
  • SPA Levers: pricing adjustments, R&Ws, indemnities, escrows/holdbacks tied to findings.

Get a personal consultation.

Let’s chat about how we can work together.

Contact Us